Further prospective analyses in lung cancer tissues are ongoing to define whether some specific CpG sites of KEAP1, either a combination of them even if not consecutive, might have a better predictive or prognostic role in lung cancer patients. This evidence concerns the gene KEAP1 and lung cancer.